- Ivermectin and COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial- a marked reduction of self-reported anosmia/hyposmia, a reduction of cough and a tendency to lower viral loads and lower IgG titers which warrants assessment in larger trials https://www.thelancet.com/journals/eclinm/article/piis2589-5370(20)30464-8/fulltext 12 comments science